TAC or Total active cannabinoids represents the total amount of active cannabinoids at the time of lab testing. This figure includes all of the active compounds that the product holds.
THC is the primary cannabinoid responsible for the psychoactive effects associated with cannabis. The amount of THC in a product can vary widely based on the method of consumption and the strain at the source of that product. The high that is produced is often enhanced by the “entourage effect” which is a combination of multiple cannabinoids in conjunction with various terpenes and individual body chemistry.
CBD is the second most prevalent cannabinoid and is primarily produced by hemp plants and at lower amounts in cannabis. CBD has soared in popularity due to its non-psychoactive effects.
Thrive tablets combine an ideal ratio of CBD, THC, and THCV, to help address stress and anxiety and promote focus and concentration. THCV, or Tetrahydrocannabivarin, is a cannabinoid found in cannabis plants that is described as having uplifting, stimulating, and clear-headed effects. Thrive tablets use Curio’s proprietary pulse-release technology which delivers the cannabinoids in two doses for sustained performance and enhanced effectiveness. The Curio Product Innovation team conducted a patient trial to evaluate the effectiveness of the Thrive formula to help find the optimum dosage. The results found were that Thrive tablets may be suitable for anyone looking for clear-headed, focused daytime relief, long-lasting effects, and discreet, reliable dosing. It is recommended to take one Thrive tablet in the morning, early afternoon, or any time patients need to focus and relieve stress.